“…It is characterized by aberrantly activated lung epithelial cells, inflammatory infiltrate, activation of lung fibroblasts, and excessive accumulation of extracellular matrix (ECM) in lung tissues that ultimately lead to respiratory failure, and eventually death if left untreated [ 7 , 8 ]. An array of triggers, including environmental pollutants, herbicides, drug side effects, particles, genetic abnormalities, autoimmune disorders, chronic infection, and cigarette smoking may cause IPF [ 9 , 10 , 11 , 12 ]. Nearly 200,000 people in the United States and over 5 million people worldwide are affected by IPF, and approximately 82–83% of deaths, incident cases, and prevalent cases occur in patients over 70 years old, imposing a great economic burden on the country as well as individuals [ 13 , 14 , 15 ].…”